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Mechanical propertiesTumor invasion and metastasis are key aspects of non-small cell lung cancer (NSCLC). During migration, cells
undergo mechanical alterations. The mechanical phenotype of breast cancer cells is correlated with aromatase
gene expression. We have previously shown that targeting aromatase is a promising strategy for NSCLC. The
aim of this study was to examine morphological and mechanical changes of NSCLC cells, upon treatment with
aromatase inhibitor and correlate their ability to migrate and invade. In vitro experiments were performed
using H23 and A549 NSCLC cell lines and exemestane was used for aromatase inhibition. We demonstrated
that exemestane reduced H23 cell migration and invasion and caused changes in cell morphology including
increased vacuolar structures and greater pleomorphism. In addition, exemestane changed the distribution of
α-tubulin in H23 and A549 cells in a way that might destabilize microtubules polymerization. These effects
were associated with increased cell viscosity and decreased elastic shear modulus. Although exemestane caused
similar effects inA549 cells regarding viscosity and elastic shearmodulus, it did not affect A549 cellmigration and
caused an increase in invasion. The increased invasion was in line with vimentin perinuclear localization. Our
data show that the treatment of NSCLC cells with an aromatase inhibitor not only affects cell migration and inva-
sion but also alters the mechanical properties of the cells. It suggests that the different origin of cancer cells is
associated with different morphological characteristics and mechanical behavior.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Non-small-cell lung cancer (NSCLC) is the most commonmalignan-
cy worldwide in both sexes and it is responsible for more than one
million deaths annually [1]. Despite the promising actions of new ther-
apeutic regimens, the survival of NSCLC patients is still poor with more
than 65% of patients with NSCLC presenting with advanced or metasta-
tic disease at the time of diagnosis [2]. In fact, metastasis is the leading
cause of death in these patients; thus unveiling that the mechanism of
tumor progression and metastasis is of great importance [2]. Cancer
cells have the ability to invade tissues and spread from their initial site
to distant organs [3]. The initial steps of local invasion include theand Biomedical Engineering,
g, Department of Mechanical
Patra 26504, Greece. Tel.: +30
ology, Division of Oncology,
niversity of Patras, Rion, 26504,
ssiou), kalofonos@upatras.gractivation of signaling pathways that control cytoskeletal dynamics of
tumor cells, the turnover of cell–matrix and cell–cell junctions. These
steps are followed by active tumor cellmigration followedbymetastasis
to distant organs [4].
It is nowwell documented that cell microenvironment regulates cell
movement. The physical and chemical properties of the extracellular
matrix facilitate the conversion of the cell surface mechanical cues to
biochemical response and hence the ability of the cells to sense theirmi-
croenvironment and adjust accordingly [5–7]. Themechanical response
of cells during migration includes cell micro-structural changes, alter-
ation in cell deformability and function as well as changes in cell ability
to migrate [8]. Recent studies suggest that changes in the mechanical
characteristics in cells reﬂect changes in cytoskeletal structure and com-
position that facilitate cell movement and/or migration [9–11]. In the
case of cancer, cell stiffness has been postulated to play a critical role
in transmigration through a basement membrane [8]. A series of
biophysical techniques have been applied to probe the mechanical
properties of cells. While cancer tissue has been found to be general-
ly stiffer than the normal, recent studies have shown that malignant
cells themselves are more compliant than normal cells [12,13]. How-
ever, correlation between cell mechanical properties and cancer
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oughly [14].
The aromatase is an enzyme complex that catalyzes the ﬁnal step
of estrogen synthesis in tissues, including breast and lung [15].
Exemestane is an irreversible steroidal aromatase inhibitor approved
for postmenopausal women with breast cancer [16]. Previous studies,
we and others have conducted, show that exemestane exerts an antitu-
mor effect in NSCLC cell lines, inhibiting cell proliferation while reduc-
ing single cell migration [17,18]. Recent evidence has correlated the
mechanical phenotype of breast cancer cells with aromatase gene ex-
pression. The authors included in cell phenotype the cell density, cell
shape and response to various culture substrates and showed that
these factors affect aromatase gene expression [19].
The aim of the current study is to address themorphological changes
and mechanical properties of NSCLC cells upon treatment with
exemestane and correlate them with the ability of cancer cells to mi-
grate and invade. Cell migration and invasion was estimated using
scratch-wound and invasion assay, respectively and the morphological
observation of cells was performed using scanning electron microscopy
(SEM). In order for the rheological andmechanical properties of the cell
lines (cell viscosity, η, and elastic shear modulus, G, respectively) to be
investigated, the micropipette technique was employed [20]. Micropi-
pette aspiration (MA) is the most feasible and convenient one in this
category, compared to AFM, theMA approach seems to bemore reliable
in representing the whole mechanical properties of a cell since it
produces a deformation of the entire suspended cell, and it eliminates
undesirable effects of cell–matrix interaction and more importantly
the stiffness of substrate [20–23]. Single-cell stiffness has recently
been recognized as a promising feature for assessment of the cell inva-
siveness and can provide new insights into the process of cancermetas-
tasis [24].
2. Materials and methods
2.1. Cell culture and reagents
NSCLC cell lines H23 (adenocarcinoma) and A549 (squamous cell
carcinoma) were purchased from the American Type Culture Collection
(ATCC, LGC Standards, Wesel, Germany) and cultured as recommended
by the manufacturer. Cells were cultured in RPMI 1640 medium with
2mMof L-glutamine and supplementedwith 1mMof sodiumpyruvate,
4.5 g/L of glucose, 1.5 g/L of sodium bicarbonate and 10% fetal bovine
serum. The culture conditions used were 37 °C, 5% CO2 and 100%
humidity.
Aromatase inhibitor, exemestane (Aromasin)was obtained by Pﬁzer
(Hellas). H23 andA549 cellswere treatedwith exemestane as previous-
ly described [25]. Exemestane was applied to cell lines after cell attach-
ment at the IC50 concentrations of 50 μM and 20 μM for H23 and A549
cells, respectively. Exemestane was then diluted in dimethyl sulfoxide
(DMSO) with its ﬁnal concentration in culture medium being 0.5%.
After reaching 50% conﬂuence, cells were washed with phosphate
buffered saline (PBS) and incubated with phenol red-free medium
(rf-medium) with 1% dextran-coated, charcoal-stripped serum (CSS)
for 24 h to deplete estrogen. Then, exemestane was added to cells and
the experiments were terminated at the indicated time point.
2.2. Scratch-wound assay
The effect of exemestane on collective cell migration was evaluated
using 2D scratch-wound assay. Cells were seeded in 6-well plates at a
density of 2 × 105 cells/well. After reaching 100% of conﬂuence, cells
were treated in the appropriate medium, rf-RPMI, with 1% CSS for
24 h. In the conﬂuent cells' monolayer, an artiﬁcial gap was created
with a yellow pipette tip. Cells were then rinsed several times with
the appropriate medium to remove dislodged cells. Exemestane was ﬁ-
nally added to cells and 24 h later images of living cells were capturedusing an inverted microscope at 4× magniﬁcation (Axiovert 40 CFL,
AxioCam ERc, Zeiss, Germany).
2.3. Invasion assay
To evaluate the effect of exemestane on cell to invasion, a boyden
chamber containing matrigel coated polycarbonate membranes with
8 μm (Invasion Chambers, BD Biosciences, Oxford, UK) was used. Cells
were cultured with rf-RPMI supplemented with 1% CSS for 24 h.
Exemestane was added to cells and 24 h later, cells were trypsinized
and resuspended at 5 × 104/0.1 ml in rf-RPMI with 1% CSS. Cell solution
was loaded in the upper chamber. The bottom chamber was ﬁlled with
0.6 ml of rf-RPMI with 10% CSS. 24 h later, the non-invading cells were
removed from the upper compartment using a cotton swab. Transwell
ﬁlters were ﬁxed with saline-buffered formalin for 10 min and then in
100%methanol for 20 min. Cells were stained in toluidine blue solution
for 10min andwashed twice in 1% PBS. Images of cells that havemigrat-
ed through the matrigel coated ﬁlter were captured using an inverted
microscope (Axiovert 40 CFL, AxioCamERc, Zeiss, Germany) at amagni-
ﬁcation of 20×.
2.4. Scanning electron microscopy (SEM)
The effect of exemestane in cell surface morphology was evaluated
with scanning electron microscopy. Cells were seeded in an 8 well cov-
erslip at a density of 3 × 104 cells/well and treated with exemestane for
24 h as described above. After the indicated incubation time, cells were
washed once with PBS and were then ﬁxed in 2.5% glutaraldehyde at
room temperature for 20 min followed by an additional washing
cycle. Subsequently, cells were dehydrated with 10%, 30%, 50%, 70%,
90% and 100% ethanol gradient for 20 min in each step. The samples
were coated with gold and examined under scanning electron micro-
scope (SEM, JEOL 6300) with an accelerating voltage of 20 kV.
2.5. Immunoﬂuorescence assay
Cells were grown in 4-well coverslips (15 × 103 cells/well) as de-
scribed above. After 24 h of incubation with exemestane, cells were
ﬁxed with saline-buffered formalin for 15 min and permeabilized with
0.1% Triton for 5 min. Blocking was performed with 3% bovine serum
albumin (BSA) in phosphate buffered saline (PBS) containing 10% FBS
for 1 h at 37 °C. After the incubation, cells were rinsed once with PBS
for 5 min and then incubated with phalloidin–ﬂuorescein isothiocya-
nate labeled (1:1000, Sigma-Aldrich, Inc., Germany), a mouse anti-
a-tubulin (1: 500, Sigma-Aldrich, Inc., Germany) or a mouse anti-
vimentin (1:100, Novocastra, UK) for 1 h at 37 °C. Cells were rinsed 3
× 5 min with PBS and then a chicken anti-mouse Alexa Fluor 594
(1:1000, Molecular Probe, Invitrogen Corporation, Camarillo, CA, USA)
diluted in blocking solution and incubation for 30 min at 37 °C was
followed. Cells were rinsed 2 × 5 min with PBS and then incubated for
5 min with Hoechst 33258 (Sigma-Aldrich, Inc., Germany); dilution in
PBS was followed for nucleus staining and cells mounted on glass
sides. Fluorescence was visualized using a Nikon microscope at 40×
magniﬁcation.
2.6. Micropipette technique
2.6.1. Micropipette aspiration
The study of the rheological and mechanical properties of cancer
cells included the measurement of cell viscosity, η, and the elastic
shear modulus, G, of cells. A micropipette aspiration technique was
used to partially aspirate the cell and obtain measurements of the re-
sulted aspirated length for a given value of negative suction pressure
being applied each time, following the method described by Evans
et al. [26]. The instrumentation and experimental set up consisted of
the borosilicate glass capillary micropipette, controlled by a mechanical
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6CN 1/2″ B/W CCD Camera), an adjustable ﬂuid reservoir for creating
ﬂuid pressure in the micropipette, a pressure transducer (DP-103,
Validyne, USA) and a monitor for digital display (“MicroPipette Vision”
I.N. SARRIS, Ltd Company) [27,28].
H23 or A549 cells, control and exemestane treated, were seeded
onto a well surface at a density of 105 cells/cm2. Two different kinds of
experiments were performed. The cell viscosity, η, was determined by
applying a constant step suction pressure (creep experiment) where
the rate of cell tongue entrance into the micropipette was recorded
and measured under a gradual increase of step pressure (ΔP) as
shown in Fig. 1. The shear elastic modulus, G, was determined by apply-
ing a very slow (isothermal change of deformation) range of suction
pressure from 0.05 kPa to 4 kPa. Four sample tests with micropipette
technique were performed for each cell type condition (treated and un-
treated), were we measured 8–10 cells per sample. Measurements of
the corresponding length of the cell tonguewere ﬁnally taken following
the procedure described by [29,30]. The diameter of cancer cell lines
were determined as 10.28 ± 2.1 μm and 10.17 ± 1.16 μm for treated
and untreated H23 cells, respectively and 8.89 ± 1.62 μm and 8.58 ±
1.96 μm for treated and untreated A549 cells, respectively.
2.6.2. Linear model of micropipette aspiration of cancer cell
In micropipette aspiration, when the micropipette radius is very
small compared to the local radius of the cell surface, the cell can be ap-
proximated as an incompressible elastic half-space, with the projection
length, L, predicted to be proportional to the aspiration pressure, ΔP.
The linear solidmodel was used to determine the elastic shearmodulus,
G. The membrane elastic shear modulus, G, was determined by the fol-
lowing equation: L/Rp = (Φp/2πG) ∗ ΔP, where L is the projection
length, Rp is the pipette radius and G, is the shear modulus, related to
the Young's modulus E, by E = 2 (1 + ν) G. Φp is a function of the
ratio of the pipette wall thickness to the pipette radius and ν is the
Poisson's ratio (ν = 0.45 and Φp = 2.0–2.1 when the ratio of the
pipette wall thickness to the radius is equal to 0.2–1.0) [20,31–33].
The cell viscosity was calculated by the equation η= E ∗ τ2 where the
τ2 (s) is the characteristic relaxation time experimentally determined
from the curve L/Dp = f(t) (Fig. 6).
2.7. Statistical analysis
The results from cell migration and invasion were statistically ana-
lyzed using Origin Pro8 SR0 (OriginLab Corporation, Northampton,
USA). Differences between groups and controls were tested by one-
way analysis of variance (ANOVA). Each experiment included a mini-
mum of three repeated measurements. All results are expressed asFig. 1.A representative image of an aspirated cancer cellwith innermicropipette diameter
Dp = 4.5 μm. The aspiration pressure, ΔP, was 488.73 Pa and the corresponding length of
cell tongue, L, was 3.7 μm. The scale bar is 4 μm.mean ± SEM from at least three independent experiments. The results
frommechanical and rheological properties of cancer cells were statisti-
cally analyzed using SPSS statistical software (version 20.0, SPSS Inc.) as
well as Matlab 7.11.0 (R2010b). Overall differences between groups
were assessed by ANOVA and individual paired comparisons were
analyzed post hoc with the Scheffe's test. Results were considered to
be statistically signiﬁcant when p b 0.05. Data are expressed as mean
value ± standard deviation (SD).
3. Results
3.1. Exemestane reduces collective cell migration in the H23 but not in the
A549 cells
In accordance with our previous results [25], we found that
exemestane reduced collective cellmigration inH23 cells in a statistical-
ly signiﬁcant manner, as shown in Fig. 2A and B, at a percentage of
15%± 4 (p b 0.05) compared to untreated cells. Moreover, exemestane
caused a reduction of A549 collective cell migration (30% ± 14) that
was not statistically signiﬁcant (Fig. 2).
3.2. Exemestane decreases the ability of H23 cells to invade
The effect of exemestane in cell invasionwas further studied using a
modiﬁed boyden chamber coated with matrigel. We found that
exemestane reduced H23 cell's ability to invade, as shown in Fig. 3A
and B, at a percentage of 38% ± 8 compared to untreated cells (p b
0.0001). In A549 cells, exemestane caused a smaller but statistically
signiﬁcant, induction of cell invasion at 8% ± 2 (p b 0.05).
3.3. Exemestane induces morphological changes in cells
Following on this, the possibility of exemestane affecting the mor-
phology of cell surface was investigated. An initial comparison of un-
treated H23 and A549 cells revealed that the former cells had more
intense cytoplasmic projections including microvilli, microridges etc.
[34]. We found that in both cell lines, exemestane affected cell surface
morphology giving genesis to apoptotic bodies and blebs as shown in
Fig. 4. Moreover, in untreated H23 cells we found vacuolar cytoplasmic
structures that were clearly observed after exemestane treatment
(Fig. 5). In addition, H23 cells treatedwith exemestaneweremore pleo-
morphic and displayed loss of cell–cell junctions (white arrows) (Fig. 5).
3.4. Exemestane induces changes in cytoskeletal components of NSCLC cells
Furthermore, we studied the effect of exemestane in cytoskeletal
network by detecting its major components such as ﬁlamentous actin
(F-actin), α-tubulin and vimentin with immunoﬂuorescence assay. In
H23 cells, we found that exemestane did not affect actin polymerization
or vimentin localization as shown in Fig. 6. However we found that
exemestane caused some changes in α-tubulin localization. In the
untreated H23 the α-tubulin distribution demonstrated a polygonal-
like morphology compared to H23 cells treated with exemestane
whereas cell morphology was more elongated (Fig. 6). In the case of
A549 cells, the treatment of exemestane did not affect F-actin localiza-
tion, however we found changes in the distribution of α-tubulin and
vimentin as shown in Fig. 7. In untreated A549 cells the α-tubulin was
located in the cytoplasm and around the nucleus demonstrating a spin-
dle shape and/or a triangle shape. After exemestane treatment cells
were more elongated and the α-tubulin was located mainly near the
cytoplasmatic membrane and not very close to the nucleus. On the
other hand, vimentin demonstrated a cytoplasmic staining in untreated
cells but after exemestane treatment, it demonstrated a perinuclear ac-
cumulation (Fig. 7).
Fig. 2. The effect of exemestane on collective cell migration of NSCLC cells. A) A representative image of scratch-wound assay from H23 and A549 cells of three independent experiments
using a magniﬁcation of 4×. B) Quantiﬁcation of the uncovered area of the images from scratch-wound assay. Results of treated cells are expressed as mean ± SEM of the % change
compared to untreated cells. Asterisks denote a statistically signiﬁcant difference compared to untreated cells. *p b 0.05.
331E. Giannopoulou et al. / Biochimica et Biophysica Acta 1853 (2015) 328–3373.5. Exemestane affects rheological and mechanical properties of NSCLC
cells
The viscosity η of H23 and A549 cells was determined applying the
standard linear viscoelastic solid model. With regards to H23 cells, the
measured viscosity was found to be 260.98 ± 149.29 (Pa·s) and
661.81 ± 281.45 (Pa·s), prior and after exemestane treatment respec-
tively (Fig. 8A and B). In A549 cells, similar changes were observed;
the viscosity was 169.82 ± 36.43 (Pa·s) and 707.73 ± 176.61 (Pa·s)
prior (Fig. 8A) and after (Fig. 8B) exemestane treatment, respectively.
Exemestane showed approximately a twofold increase of the cell vis-
cosity for both H23 (p b 0.05) and A549 (p b 0.05) cells, while reducing
the cell's movement ability. More interestingly for the case of H23 cells,
this result is in line with the inhibition of exemestane in cell migration
and invasion. However, this observation was not veriﬁed in A549 cells.
Regarding the mechanical properties of cells, elastic shear modulus
G was evaluated. In H23 cells, the G parameter was found to be
159.10 ± 62.10 Pa prior and 125.0 ± 65.05 Pa after the exemestane
treatment, respectively, compared to the A549 cells, whereby the G pa-
rameter was valued 480.0 ± 237.23 Pa prior and 269.87± 43.0 Pa afterexemestane treatment, respectively (p b 0.05). These results can be
seen in Fig. 9A and B.
Furthermore, the creep experiment data were examined for the
possibility of a power-law cell rheology. Indeed, the analysis using the
power-law model, showed similar results with the applied standard
linear solid model [35–38] (data not shown).
4. Discussion
The contribution of estrogen signaling to lung carcinogenesis is sup-
ported by an increased number of published studies with pre-clinical
and clinical data [17,25,39–41]. Both in vitro and in vivo experiments
have shown that the estrogens might facilitate lung cancer growth,
with several studies having shown that NSCLC cell lines and lung
tumor tissues express aromatase [42]. Moreover, it has been found
that in human NSCLC tumor specimens the protein levels of aromatase
are elevated in the sites of metastasis compared to the primary tumor
[43]. Metastasis is a multi-step process that requires local tumor inva-
sion, angiolymphatic transmigration and transport resulting in the
establishment of a tumor in a secondary site [44]. During invasion and
Fig. 3. The impact of exemestane on the ability of NSCLC cells to invade. A) A representative image of invasion assay from H23 and A549 cells of three independent experiments using a
magniﬁcation of 20×. B) Quantiﬁcation of images from invasion assay. Results are expressed as mean ± SEM of the % change compared to the untreated cells. Asterisks denote a statis-
tically signiﬁcant difference compared to untreated cells. *p b 0.05 and ***p b 0.0001.
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physical stimuli from the environment in order to dissociate from the
primary tumor and to enter circulation. Cells adjust their shape by
rearranging actin ﬁlaments or other cytoskeletal proteins according to
microenvironmental mechanical stimuli [34]. Very few data exist for
the role of estrogens in mechanical properties of tumor cells. A recent
publication correlates the breast cancer cell density and shape with
the aromatase expression and estrogen biosynthesis [19].
In the current study, we examined whether exemestane, an inhibi-
tor of aromatase, alters NSCLC cells' mechanical properties. Motivated
by previous results from our lab having shown that exemestane
inhibited NSCLC cell proliferation [17], single cell migration and matrix
metalloproteinases' levels [25], we further studied the effect of
exemestane in other types of cell movement such as collective cell mi-
gration and invasion, using the H23 and A549 NSCLC cell lines. We
found that exemestane inhibited H23 collective cell migration. Interest-
ingly, however, it did not have a similar effect on A549 cells. This result
is in linewith previous ﬁndings having shown that exemestane reducedsingle cellmigration inH23 cellswithout affectingA549 cells [25]. In ad-
dition, exemestane reduced the ability of H23 cell to invade while
resulting in an increase in A549 cells' invasion ability. On the other
hand, the treatment of both H23 and A549 cells with exemestane
caused changes in the distribution ofα-tubulin. This effect is due to pre-
vious studies where other investigators have shown that the estrogens
modify the polymerization of microtubules [45] probably resulting in
reduced G [46]. The increase in A549 invasion after treatment with
exemestane is in accordance with the changes in vimentin localization.
Exemestane induced a perinuclear staining of vimentin in these cells, an
effect that might promote the formation of lamellipodia [47]. The inhib-
itory effect of exemestane inH23 cells'migration and invasion is in sym-
phony with the increased cell viscosity and the decreased elastic shear
modulus. The increased cell viscosity after exemestane treatment im-
plies that treated cells have to spend more energy in order to migrate
or invade compared to untreated cells. The reduced elastic shear modu-
lus suggests that treated cells lose part of their elastic energy and hence
reduce their ability to migrate and/or invade. Notably, the effect of
Fig. 4. Exemestane induced changes such as apoptotic bodies, in the cell surface of H23 and A549 cells compared to untreated cells. Samples were analyzed under SEM. Themagniﬁcation
for H23 cells and A549 cells were ×4500 and ×2500 respectively. The scale bars are 9 μm for H23 cells and 20 μm for A549 cells. Images are representative of three independent
experiments.
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pattern.More speciﬁcally, exemestane increased A549 cell viscosity and
reduced shear stressmodulus, but it did not reduce collective cellmigra-
tion or invasion.
A possible explanation for this unexpected discrepancy between the
results of H23 and A549 cancer cell lines could be the structural hetero-
geneity of the two types of cancer cell lines. The two cell lines exert
probably different responses inmechanical stimuli due to the squamousFig. 5. Exemestane induced more changes in H23 cells compared to A549 cells, including vacuo
SEM. Themagniﬁcation was ×750 for control (ﬁrst lane) and Exe (1) (second lane) and ×500 fo
bars for the third lane are 50 μm. Images are representative of three independent experimentscomponent that is present in A549 cells' phenotype compared to the
one in H23 adenocarcinomatous cells [48]. Also, this discrepancy
between the two cell lines after exemestane treatment point out the
complexity of the invasion process and underline the difﬁculty to
predict the therapy's outcome.
It is widely accepted that high shear stress modulus is associated
with high elastic energy (elastic energy ~ elasticmodulus) and therefore
high ability for cell contraction and eventually increased cellmovement.lar structures and loss of cell–cell junctions (white arrows). Samples were analyzed under
r Exe (2) (third lane). The scale bars for the ﬁrst and second lanes are 70 μm and the scale
.
Fig. 6. The effect of exemestane on cytoskeletal components such as F-actin, a-tubulin and vimentin in H23 cells. Con: the untreated cells, Exe: cells treated with exemestane for 24 h.
F-actin is stained with phalloidin-FITC (green ﬂuorescence), α-tubulin and vimentin are shown with red ﬂuorescence. Nucleus is shown with blue ﬂuorescence. The image is represen-
tative of three independent experiments using a magniﬁcation of 40×. The scale bars are 20 μm.
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reﬂects a dissipation of energy. According to cell invasion process and
its mechanical behavior, tumor cell invasion is a complicated andmulti-
factorial process that involves attachment to, degradation of, and
detachment from an extracellular matrix and ﬁnally active migration
[49]. The elastic energy of an isolated cell which is expressed by cell
dynamics is derived from a dynamic interplay between cell protrusion,
adhesion and contraction activities which is resulted from the interac-
tion among microtubule dynamics, actomyosin contractility and
adhesion-dependent signaling. The transition from one stage to the
other requires reorganization of the cytoskeleton which takes place by
microtubules disruption leading to a signiﬁcant increase in actomyosin
contractility and promotion of the focal adhesion with actin microﬁla-
ment bundles [50], implying changes of mechanical and rheological be-
havior of the cell presenting different elastic moduli and elastic energy
in every stage of process. An isolated cell in the prestress stage as well
as in the attachment stage is a cell with high elastic energy and a high
elastic shear modulus. The stiffness of the cell structure in this stage
may imply strong springs and reﬂects a quite different situation with
the stiffness of the apoptotic cells. When the cytoskeleton is disrupted,
the cell's elasticmodulus decreases. It becomesmore viscous as other in-
vestigators have shownbymeasuring themagnitude reduction between
elasticmodulusG′ and lostmodulusG″, suggesting that the cell becomes
more liquid like [46]. We observed that exemestane caused a greater
reduction in shear modulus in A549 cells compared to H23 cells. Thisﬁnding supports the notion that the dissipation of energy is augmented
in A549 cells. A possible explanation for this difference might be attrib-
uted to our electron microscopy ﬁndings that H23 cells have more
pronounced cytoplasmic projections, a feature that may be associated
with impediment of energy dissipation. Furthermore, the electron
microscopy analysis revealed cell surface abnormalities like apoptotic
bodies and blebs. The observation of blebs in the exemestane-treated
cells is consistent with the observation that the treatment caused a de-
crease in their shear modulus. This effect was expected given our previ-
ousﬁndings that exemestane can induce apoptosis in both cell lines [25].
As can been seen, we approached the mechanical behavior of H23
and A549 cancer cell lines using themicropipettemethod and the linear
viscoelastic model [8,21,51], as well as with the power-law model
[35–38]. It is important to highlight that the interpretation of experi-
mental data might be affected by different choices of models [20]. It is
also necessary to distinguish between small deformation experiments
and large deformation ones [52]. In our experimentswe observedmain-
ly small deformations and in some cases large deformations. The large
deformation may imply disruption of the crosslinked cytoskeleton and
therefore contradictions between the results could be inevitable. In
the case of small deformation the linear viscoelastic model would be
more appropriate to explain the mechanical and rheological behavior
of the cell line than other models.
Collectively, in the present study it has been shown that the treat-
ment of NSCLC cells with an aromatase inhibitor not only affects cell
Fig. 7. The effect of exemestane on cytoskeletal components such as F-actin, a-tubulin and vimentin in A549 cells. Con: the untreated cells, Exe: cells treated with exemestane for 24 h.
F-actin is stained with phalloidin-FITC (green ﬂuorescence), α-tubulin and vimentin are shown with red ﬂuorescence. Nucleus is shown with blue ﬂuorescence. The image is represen-
tative of three independent experiments using a magniﬁcation of 40×. The scale bars are 20 μm.
335E. Giannopoulou et al. / Biochimica et Biophysica Acta 1853 (2015) 328–337migration and invasion but also the cell's mechanical properties. Our
ﬁndings imply that the determination of the cell mechanical properties
cannot overall predict themigration and/or invasion ability of cancerous
cells underlying the heterogeneity of lung cancer [53].BA
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